Online Tirzepatide Weight-Loss Therapy

Tirzepatide is the first dual GIP/GLP-1 receptor agonist, outperforming semaglutide in clinical trials for both A1C reduction and weight loss.*

• Weekly self-injection or daily rapid-dissolve tablet
• Average TBTotal.Health result: 17-25 lb lost within six months
• Added cardiovascular and metabolic benefits

Cost Snapshot

• Telehealth evaluation: $99
• Medication from ≈ $179 / month

Schedule Your Telemedicine Tirzepatide Online Today! → Schedule Appointment